Research.Patient.info
Malignant Primary Gliomas research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE1
5G-EMERALD: Amivantamab in Malignant Brain Tumours
This study, called 5G-EMERALD, is testing a new drug called amivantamab for people with certain types of aggressive brain tumours. It aims to see if the drug is safe and if it helps shrink tumours, especially in patients whose tumours have a specific genetic feature.
United Kingdom - recruitingPHASE1, PHASE2
5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
This study is testing two new drugs, avutometinib and defactinib, alone and with temozolomide, for people with aggressive brain tumours like glioblastoma. It aims to see if they are safe and can shrink tumours, particularly in patients with specific genetic changes.
United Kingdom